We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+7.1%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.69B
AUM Growth
+$214M
Cap. Flow
+$72.4M
Cap. Flow %
2.69%
Top 10 Hldgs %
36.8%
Holding
3,484
New
256
Increased
1,490
Reduced
872
Closed
231
Avg Time Held Equity + Options
2.8 years
Top 10 Avg Time Held Equity + Options
2.2 years
Top 20 Avg Time Held Equity + Options
2.1 years
Avg Time Held Equity only
2.8 years
Top 10 Avg Time Held Equity only
2.2 years
Top 20 Avg Time Held Equity only
2.1 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 51.24%
2 Technology 16.87%
3 Financials 7.26%
4 Healthcare 6.41%
5 Consumer Discretionary 5.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
JRVR icon
3176
James River Group Holdings
JRVR
$173M
– –
-67
Closed -$3K –
KALA icon
3177
KALA BIO
KALA
$3.77M
– –
0
– –
2021 Q1
3 quarters
KALU icon
3178
Kaiser Aluminum
KALU
$2.42B
$0 ﹤0.01%
+1
New +$101
2021 Q4
0 quarters
KALV icon
3179
DELISTED
KalVista Pharmaceuticals
KALV
– –
-8
Closed – –
KIDS icon
3180
OrthoPediatrics
KIDS
$592M
– –
-65
Closed -$4K –
KNSA icon
3181
Kiniksa Pharmaceuticals
KNSA
$6.35B
$0 ﹤0.01%
+24
New +$295
2021 Q4
0 quarters
KOPN icon
3182
Kopin
KOPN
$677M
– –
-10,413
Closed -$53K –
KOS icon
3183
Kosmos Energy
KOS
$1.61B
$0 ﹤0.01%
+68
New +$244
2021 Q4
0 quarters
KREF icon
3184
KKR Real Estate Finance Trust
KREF
$351M
– –
-18
Closed – –
KRON icon
3185
DELISTED
Kronos Bio
KRON
– –
-211
Closed -$4K –
KVHI icon
3186
KVH Industries
KVHI
$109M
$0 ﹤0.01%
29
– –
2020 Q3
5 quarters
LBTYK icon
3187
Liberty Global Class C
LBTYK
$2.7B
$0 ﹤0.01%
6
-5
-45% -$143
2020 Q4
4 quarters
LGND icon
3188
Ligand Pharmaceuticals
LGND
$5.96B
$0 ﹤0.01%
5
– –
2021 Q3
1 quarter
LIVN icon
3189
LivaNova
LIVN
$4.33B
$0 ﹤0.01%
1
-3
-75% -$250
2021 Q3
1 quarter
LNSR icon
3190
LENSAR
LNSR
$74.6M
– –
-26
Closed – –
LSF icon
3191
Laird Superfood
LSF
$30.3M
– –
-50
Closed -$1K –
LSPD icon
3192
Lightspeed Commerce
LSPD
$1.42B
$0 ﹤0.01%
1
-80
-99% -$5.46K
2020 Q4
4 quarters
LTPZ icon
3193
PIMCO 15+ Year US TIPS Index Exchange-Traded Fund
LTPZ
$1.1B
$0 ﹤0.01%
1
– –
2020 Q4
4 quarters
MEC icon
3194
Mayville Engineering Co
MEC
$363M
– –
-41
Closed -$1K –
MED icon
3195
Medifast
MED
$135M
– –
-20
Closed -$4K –
MFIC icon
3196
MidCap Financial Investment
MFIC
$701M
$0 ﹤0.01%
+9
New +$118
2021 Q4
0 quarters
MGNI icon
3197
Magnite
MGNI
$3.48B
– –
-36
Closed -$1K –
MHO icon
3198
M/I Homes
MHO
$3.19B
– –
-7
Closed – –
MRIN
3199
DELISTED
Marin Software
MRIN
– –
-10
Closed -$1K –
MVBF icon
3200
MVB Financial
MVBF
$376M
– –
-17
Closed -$1K –

Similar funds

Parallel Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Parallel Advisors held 3,484 positions worth $2.69B, up 8.6% from $2.48B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q4 2021 filing shows 256 new, 1,490 increased, 872 reduced and 231 closed positions. Its largest new stake was Payoneer: 1,784,455 shares worth $13.1M. The largest sale was iShares US Treasury Bond ETF, an estimated $17.7M.

By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 52% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2021 buy was Payoneer: 1,784,455 shares worth $13.1M.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $29.6M increase.
  • Parallel Advisors's biggest Q4 2021 reduction was iShares US Treasury Bond ETF, cutting an estimated $17.7M.
  • Parallel Advisors fully exited FTAC Olympus Acquisition Corp. Class A Ordinary Shares in Q4 2021, selling an estimated $15.5M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.69B portfolio in Q4 2021.
  • Parallel Advisors opened 256 new positions and closed 231 in Q4 2021.
  • Parallel Advisors's portfolio value rose 8.6% quarter-over-quarter to $2.69B.

Based on Parallel Advisors's 13F filing for Q4 2021, filed 20 Jan 2022.